Tertiary Lymphoid Structures as Mediators of Immunotherapy Response

Area of Science:

• Immunology
• Oncology
• Pathology

Background:

• Immunotherapy is a leading cancer treatment strategy with variable patient responses.
• Traditional biomarkers do not always predict immunotherapy efficacy.
• Tumor-like structures (TLS) are emerging as critical determinants of patient outcomes in malignancy.

Purpose of the Study:

• To review the mechanistic underpinnings of TLS formation.
• To examine the relationship between TLS and various malignancies.
• To explore the role of TLS in immunotherapy function and efficacy prediction.

Main Methods:

• Literature review of mechanistic studies on TLS formation.
• Analysis of pathological data correlating TLS characteristics with malignancy.
• Synthesis of evidence on TLS's role in predicting and modulating immunotherapy response.

Main Results:

• TLS are distinct immunologic structures found in various malignancies.
• TLS presence, location, composition, and maturity are crucial for host anti-malignancy response.
• TLS represent potential biomarkers for predicting immunotherapy efficacy and targets for enhancing treatment.

Conclusions:

• TLS play a significant role in the host's response to malignancy.
• TLS are promising candidates for predicting and enhancing immunotherapy efficacy.
• Further research into TLS is warranted to optimize cancer treatment strategies.